Although two studies have reported that exogenous and endogenous cannabinoids attenuate autoimmune hepatitis, in contrast to our results15,31, the beneficial effects were upon simultaneous engagement of both CB1 and CB2 receptors. Here, CNR1 is linked to autoimmune hepatitis.